Search Results - Snow-Adami, L.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    P.3.c.057 Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia

    P.3.c.057 Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia by Mackle, M, Snow-Adami, L, Zhao, J, Szegedi, A, Panagides, J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P.3.c.046 Long-term safety and maintenance of effect of asenapine in patients with acute exacerbation of schizophrenia

    P.3.c.046 Long-term safety and maintenance of effect of asenapine in patients with acute exacerbation of schizophrenia by Meltzer, H, Cohen, M, Snow-Adami, L, Mackle, M, Zhao, J, Szegedi, A, Panagides, J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Initial clinical profile of the PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia

    Initial clinical profile of the PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia by Mukai, Y., Lupinacci, R., Marder, S., Mackle, M., Snow-Adami, L., Voss, T., Smith, S.M., Egan, M.F., Kent, J.

    Published in Neuroscience Applied
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder

    Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I... by Landbloom, Ronald L, Mackle, Mary, Wu, Xiao, Kelly, Linda, Snow-Adami, Linda, McIntyre, Roger S, Mathews, Maju, Hundt, Carla

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial

    Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial by Findling, Robert L., Landbloom, Ronald L., Mackle, Mary, Wu, Xiao, Snow-Adami, Linda, Chang, Kiki, Durgam, Suresh

    Published in Paediatric drugs
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder

    Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I d... by Landbloom, Ronald L., Mackle, Mary, Wu, Xiao, Kelly, Linda, Snow-Adami, Linda, McIntyre, Roger S., Mathews, Maju, Hundt, Carla

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: